Effects of a Structured, Family-supported, Patient-centred Advance Care Planning for End-of-life Decision Among Palliative Care Patients and Their Family Members: a Randomized Controlled Trial
Led by The Hong Kong Polytechnic University · Updated on 2024-10-10
170
Participants Needed
3
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
Research Team
How is the study designed?
Similar Trials
Frequently Asked Questions
Research Publications
Sponsors
T
The Hong Kong Polytechnic University
Lead Sponsor
S
Shatin Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating the effectiveness of a structured, family-supported, patient-centred advance care planning (ACP) program for adult palliative care patients and their family members. This randomized controlled trial aims to determine if the ACP-Family intervention improves end-of-life decision making and psychological outcomes compared to usual palliative care. The study also explores whether the type of hospital setting influences the intervention's effectiveness.
Participants will be randomly assigned to one of two groups: the ACP-Family group or the usual care group (ACP-UC). The ACP-Family intervention involves two face-to-face sessions lasting 45 to 60 minutes each, delivered within one month by a trained ACP facilitator. These sessions cover five key elements of advance care planning, including understanding illness, values and beliefs, possible future health conditions, advance directives, and the role of a substituted decision maker. If patients are discharged before completing the sessions, treatment continues at home. The usual care group receives standard palliative care available at the hospital.
During the study, researchers will assess participants at 6 and 12 months to measure the accuracy of family members' predictions of patients' treatment preferences, new ACP documentation, whether patients' end-of-life care preferences were respected, patients' decisional conflict, quality of communication, and family members' decision-making confidence and mental health. All discussion sessions in the ACP group will be recorded for quality assurance. The total participation duration includes follow-ups at 6 and 12 months to monitor these outcomes and satisfaction with the intervention.
CONDITIONS
Brief Title
ACP-Family Programme for Palliative Care Patients and Their Family Member
Who Can Participate
Age: 18Years - 120Years
All Genders
Eligibility Criteria
You may qualify if you...
Patient aged 18 years or older
Receiving palliative care at the study hospitals
Able to communicate in Cantonese
Cognitively intact with an Abbreviated Mental Test (AMT) score of 7 or higher
Family member aged 18 years or older
Family member able to communicate in Cantonese
Family member nominated by the patient and likely to make future substituted health care decisions
You will not qualify if you...
Currently engaging in advance care planning discussions with healthcare professionals in the hospital
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Within 1 month
Participants receive two face-to-face sessions of the family-supported, patient-centred ACP programme within one month, delivered by a trained ACP facilitator. Sessions may continue at home if the patient is discharged before completion.
2 visits (in-person) lasting 45-60 minutes each
Follow-up
Duration - 12 months
Participants are followed up to assess outcomes related to end-of-life decision making and psychological measures.
Effects of a structured, family-supported, and patient-centred advance care planning on end-of-life decision making among palliative care patients and their family members: protocol of a randomised controlled trial.
Doris Y P Leung, Joyce O K Chung, Helen Y L Chan...